Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk.
The ease of measurement and the quantitative nature of bone mineral densitometry (BMD) is clinically appealing. Despite BMD's proven capability to stratify fracture risk, data indicate that clinical risk factors provide complementary information on fracture susceptibility that is independent of BMD. Methods to quantify fracture risk using both clinical and BMD variables would have great appeal for clinical decision-making. We describe a procedure for quantifying hip fracture risk (5-yr and remaining lifetime) based on (1) the individual's age alone (base model, assuming average clinical risk factors and bone density), (2) incorporation of multiple patient-specific clinical risk factor data in the base model, and (3) incorporation of both patient-specific clinical risk factor data and BMD results.
Department of Medicine, Faculty of Medicine, University of Manitoba, Winnipeg, Canada. BLeslie@sbgh.mb.ca
William D
WD
Leslie
Colleen
C
Metge
Elizabeth A
EA
Salamon
C Kin
CK
Yuen
D000367:Age Factors; D000368:Aged; D015519:Bone Density; D003720:Densitometry; D005260:Female; D006620:Hip Fractures / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D009010:Monte Carlo Method; D015663:Osteoporosis, Postmenopausal / Q000150:complications* / Q000503:physiopathology; D011237:Predictive Value of Tests; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors